ICRS depth less than expected using OCT

Article

Depth of intrastromal corneal ring segments (ICRS) is less than expected in myopic patients when measured by OCT, claims a recent paper.

Depth of intrastromal corneal ring segments (ICRS) is less than expected in myopic patients when measured by OCT, claims a recent paper.

Dr M. Naftali et al., Ophthalmology Unit of the Baruch Padeh Medical Centre, Poriya, Israel, included ten eyes of eight patients with 18 ICRS in a retrospective, comparative study.

Eleven ICRSs were Intacs and seven were Kerarings. AS-OCT was used to measure the shortest distance from the epithelium to the segment at three points. These points were proximal, middle and distal to the incision.

Mean depth of the 18 segments was 360±68 µm and the mean maximal and minimal depths were 383±70 and 336±72 µm, respectively. Mean depths of the proximal, middle and distal points were 358±79, 361±77 and 362±59 µm, respectively.

There were no segments that appeared more superficial than others and there were no differences between Intacs and Kerarings depths. However, there was a significant difference between the expected ICRS depth and OCT measurement, with ICRS depth being less than expected.

The abstract can be viewed in the European Journal of Ophthalmology.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.